12/24
11:23 am
tvrd
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Low
Report
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
12/23
10:18 am
tvrd
INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Low
Report
INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
12/21
10:11 am
tvrd
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Neutral
Report
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
12/21
01:08 am
tvrd
Tvardi Therapeutics (NASDAQ:TVRD) was upgraded by analysts at
Wall Stree
Neutral
Report
Tvardi Therapeutics (NASDAQ:TVRD) was upgraded by analysts at
Wall Stree
12/20
08:01 am
tvrd
SHAREHOLDER INVESTOR REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Neutral
Report
SHAREHOLDER INVESTOR REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
12/17
10:31 am
tvrd
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Medium
Report
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
12/11
10:15 am
tvrd
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Low
Report
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
12/4
10:28 am
tvrd
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Low
Report
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
12/3
09:50 am
tvrd
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Medium
Report
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
11/30
09:46 am
tvrd
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Medium
Report
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
11/29
08:51 am
tvrd
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Medium
Report
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
11/25
01:58 pm
tvrd
Tvardi Therapeutics (NASDAQ:TVRD) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Tvardi Therapeutics (NASDAQ:TVRD) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
11/21
10:08 am
tvrd
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Low
Report
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
11/20
02:36 pm
tvrd
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Low
Report
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
11/18
01:22 pm
tvrd
Tvardi Therapeutics (NASDAQ:TVRD) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Tvardi Therapeutics (NASDAQ:TVRD) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
11/18
08:00 am
tvrd
Tvardi Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
Medium
Report
Tvardi Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/14
10:31 am
tvrd
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Tvardi
Medium
Report
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Tvardi
11/12
01:30 pm
tvrd
Tvardi Therapeutics (NASDAQ:TVRD) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Tvardi Therapeutics (NASDAQ:TVRD) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
11/12
10:10 am
tvrd
TVRD Investors Have Opportunity to Join Tvardi Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
Low
Report
TVRD Investors Have Opportunity to Join Tvardi Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
11/9
09:18 am
tvrd
TVRD SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Low
Report
TVRD SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
11/7
01:15 am
tvrd
Tvardi Therapeutics (NASDAQ:TVRD) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Tvardi Therapeutics (NASDAQ:TVRD) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
11/6
11:07 am
tvrd
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Tvardi
Low
Report
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Tvardi
11/5
10:40 am
tvrd
TVRD Investors Have Opportunity to Join Tvardi Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
Low
Report
TVRD Investors Have Opportunity to Join Tvardi Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
11/4
11:41 am
tvrd
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Medium
Report
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
11/4
08:00 am
tvrd
Tvardi Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
Low
Report
Tvardi Therapeutics to Participate in the Jefferies Global Healthcare Conference in London